STOCK TITAN

Binder sells 179,419 ARLO shares under 10b5-1 (ARLO)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ARLO reporting a Form 144 notice for sales of Common stock by Kurtis Binder. The filing lists multiple 10b5-1 plan sales including 179,419 shares on 03/12/2026 for $2,471,532.61, 12,539 shares on 03/03/2026 for $187,183.45, and other sales in early 2026. It also records an award of 25,000 Performance Stock Units dated 07/30/2024.

Positive

  • None.

Negative

  • None.
Sale - 03/12/2026 179,419 shares sale date 03/12/2026
Proceeds - 03/12/2026 $2,471,532.61 gross proceeds for 179,419 shares
Sale - 03/04/2026 9,665 shares sale date 03/04/2026
Proceeds - 03/03/2026 $187,183.45 gross proceeds for 12,539 shares on 03/03/2026
Performance Stock Units 25,000 units PSU grant dated 07/30/2024
10b5-1 regulatory
"10b5-1 Sales for KURTIS BINDER"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Performance Stock Units financial
"Performance Stock Units | Issuer | 25,000 | 07/30/2024"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
Form 144 regulatory
"144: Securities Sold During The Past 3 Months"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does ARLO's Form 144 show about Kurtis Binder's stock sales?

The Form 144 shows multiple sales by Kurtis Binder under a 10b5-1 plan. The filing lists sales such as 179,419 shares on 03/12/2026 for $2,471,532.61, and earlier 2026 sales with share counts and gross proceeds recorded.

How many shares and proceeds are listed for the largest sale in the ARLO Form 144?

The largest listed sale is 179,419 shares on 03/12/2026 with gross proceeds of $2,471,532.61. The filing records each sale with date, share count, and proceeds for reporting purposes.

Does the filing mention any equity awards for ARLO personnel?

Yes, the filing records an award of 25,000 Performance Stock Units dated 07/30/2024. The award entry appears in the securities-to-be-sold section alongside issuer labeling.

Were the sales executed under a trading plan according to the Form 144?

Yes, the filing explicitly notes these as 10b5-1 sales for Kurtis Binder. The entries label several transactions as being effected pursuant to a 10b5-1 sales plan, with dates and proceeds shown.